Long-Term Visual Acuity Outcomes Of Extended Macular Vision Iol Implantation In Macular Scar: A Case Report

Purpose: To report the long-term visual outcomes of an extended macular vision intraocular lens (IOL) in a case of macular scar and visually insignificant cataract. The study focuses on changes in corrected distance visual acuity (CDVA) and corrected near visual acuity (CNVA) over a 24-month follow-up period.

Setting/Venue: Micro Chirurgia Oculare, Milan, Italy

Report: A 75-year-old male patient with a left macular scar and a clinically nonsignificant cataract (NC1) underwent phacoemulsification with implantation of an Eyemax Mono IOL, an extended macular vision IOL designed to optimize visual performance within 10 degrees from the foveal center, in patients with macular pathology. Hypermetropia was targeted to achieve magnification with spectacles. The study focuses on changes in corrected distance visual acuity (CDVA) and corrected near visual acuity (CNVA) 24 months postoperatively. At 24 months postoperatively, the spherical equivalent was +2.25D. LogMAR CDVA improved from 0.4 to 0.15, demonstrating a two-line gain. LogMAR CNVA improved significantly from 1.36 to 0.18, corresponding to a 12-line improvement with a +3.25D near add. Intraocular pressure remained stable at 14 mmHg.

Conclusions: Eyemax Mono IOL implantation resulted in substantial improvements in both distance and near visual acuity in a patient with a macular scar. The gain in CNVA suggests enhanced functional vision for near tasks. These findings support the potential of extended macular vision IOLs in improving vision for patients with macular pathology. Further studies with larger cohorts are warranted to confirm these results.